Both in Pharmaceuticals
Amylyx Pharmaceuticals vs Dyne Therapeutics
Over the past year AMLX returned +114.0% and DYN returned −13.8%; their daily moves had a correlation of 0.39.
AMLX +114.0% DYN −13.8%Growth of $1, one year, split-adjusted
| Metric | AMLX | DYN |
|---|---|---|
| Price | $29.40 | $18.54 |
| Market cap | $3.69B | $3.46B |
| Today | +0.68% | +2.71% |
| 1 month | +4.9% | +20.4% |
| 6 months | +83.1% | −1.6% |
| Year to date | +143.4% | −5.2% |
| 1 year | +116.2% | −23.1% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $250.8M | $685.0M |
| Dividend yield | — | — |
| Volatility (60d) | 112.2% | 59.8% |
| Short % of float | 13.7% | 14.6% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).